Investors

Insider Transactions

Date Name Title Type Sorted Ascending Shares Traded Price Range
Jan 31, 2014 sanofi Beneficial Owner (10% or more) Buy 10,914 286.13 - 289.90
Feb 3, 2014 sanofi Beneficial Owner (10% or more) Buy 198,058 279.14 - 289.62
Nov 13, 2009 sing george l Director Buy 10,000 18.78
Nov 13, 2009 sing george l Director Buy 2,500 18.68 - 18.72
May 18, 2010 sing george l Director Buy 5,000 28.44
May 18, 2010 sing george l Director Buy 2,500 28.64
Nov 26, 2013 baker charles a Director Disposition (Non Open Market) 590 n/a
Nov 24, 2014 brown michael s Director Disposition (Non Open Market) 2,000 n/a
Jul 31, 2014 brown michael s Director Disposition (Non Open Market) 2,700 n/a
Jul 30, 2014 brown michael s Director Disposition (Non Open Market) 5,687 n/a
Jul 17, 2014 brown michael s Director Disposition (Non Open Market) 14,662 n/a
Nov 2, 2009 brown michael s Director Disposition (Non Open Market) 12,000 n/a
May 18, 2010 brown michael s Director Disposition (Non Open Market) 4,476 28.40
Dec 22, 2010 brown michael s Director Disposition (Non Open Market) 5,000 n/a
Dec 19, 2008 gilman alfred g Director Disposition (Non Open Market) 1,000 n/a
Dec 12, 2007 gilman alfred g Director Disposition (Non Open Market) 2,000 n/a
Dec 17, 2007 gilman alfred g Director Disposition (Non Open Market) 1,500 n/a
Dec 19, 2007 gilman alfred g Director Disposition (Non Open Market) 500 n/a
Dec 24, 2007 gilman alfred g Director Disposition (Non Open Market) 500 n/a
Nov 17, 2009 gilman alfred g Director Disposition (Non Open Market) 2,000 n/a
Showing 401-420 of 920 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)